| Literature DB >> 2511811 |
M Germond1, M C Gaillard, A Senn.
Abstract
The ovarian hyperstimulation syndrome (SHO) can be defined as an iatrogenic pathology induced by active substances administered for controlling follicular maturation and ovulation. The etiology, the physiopathology, the diagnostic and therapeutic methods available are discussed. A theoretical model, based on clinical data, allows identification of a set of criteria which should help determining prospectively the chances of development of such a pathology.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2511811 DOI: 10.1007/bf00935853
Source DB: PubMed Journal: Arch Gynecol Obstet ISSN: 0932-0067 Impact factor: 2.344